A crazy trio in Parkinson's disease: metabolism alteration, α-synuclein aggregation, and oxidative stress

Mol Cell Biochem. 2024 Apr 16. doi: 10.1007/s11010-024-04985-3. Online ahead of print.ABSTRACTParkinson's disease (PD) is an aging-associated neurodegenerative disorder, characterized by the progressive loss of dopaminergic neurons in the pars compacta of the substantia nigra and the presence of Lewy bodies containing α-synuclein within these neurons. Oligomeric α-synuclein exerts neurotoxic effects through mitochondrial dysfunction, glial cell inflammatory response, lysosomal dysfunction and so on. α-synuclein aggregation, often accompanied by oxidative stress, is generally considered to be a key factor in PD pathology. At present, emerging evidences suggest that metabolism alteration is closely associated with α-synuclein aggregation and PD progression, and improvement of key molecules in metabolism might be potentially beneficial in PD treatment. In this review, we highlight the tripartite relationship among metabolic changes, α-synuclein aggregation, and oxidative stress in PD, and offer updated insights into the treatments of PD, aiming to deepen our understanding of PD pathogenesis and explore new therapeutic strategies for the disease.PMID:38625515 | DOI:10.1007/s11010-024-04985-3
Source: Molecular and Cellular Biochemistry - Category: Biochemistry Authors: Source Type: research